Autopsy report · NCT01675011

Embozene Microspheres for Uterine Fibroid Embolization (UFE)

“Inadequate enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 4 months before it stopped.
• 4 participants enrolled.
• Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Boston Scientific Corporation

Sponsor type

Industry

Conditions

Uterine Fibroids

Interventions

Embozene® Microspheres; Embosphere®

Participants

4

Sites

2

Countries

United States

Trials that died the same way

• Prophylactic Phenobarbital After Neonatal Seizures
  “Inadequate rate of enrollment” (92% match in meaning)
• Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb Ischemia
  “Lack of enrollment” (92% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.